CTLA4-IgG4m (RG2077)

CTLA4-IgG4m

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CTLA4-IgG4m (RG2077), covering 2017-01-11 to 2017-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) [Phase 1, Phase 2]